{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470611500
| IUPAC_name = 2-[(3-chloro-2-methylphenyl)amino]benzoic acid)<ref name="Andersen">{{cite journal | author = Kim Vilbour Andersen, Sine Larsen, Børge Alhede, Niels Gelting and Ole Buchardt | url = http://www.rsc.org/Publishing/Journals/P2/article.asp?doi = P29890001443 | title = Characterization of two polymorphic forms of tolfenamic acid, N-(2-methyl-3-chlorophenyl)anthranilic acid: their crystal structures and relative stabilities | journal = J. Chem. Soc., Perkin Trans. 2 | year = 1989 | issue = 10 | pages = 1443–1447 | doi = 10.1039/P29890001443}}</ref>
| image = Tolfenamic acid FormulaV1.svg
| width = 220

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|tolfenamic-acid}}
| routes_of_administration = oral
| legal_AU = S4

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 13710-19-5
| ATC_prefix = M01
| ATC_suffix = AG02
| PubChem = 610479
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 530683
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 3G943U18KM
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01183
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 32243
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 121626

<!--Chemical data-->
| C=14 | H=12 | Cl=1 | N=1 | O=2 
| molecular_weight = 261.707 g/mol
| smiles = Clc2cccc(Nc1ccccc1C(=O)O)c2C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H12ClNO2/c1-9-11(15)6-4-8-12(9)16-13-7-3-2-5-10(13)14(17)18/h2-8,16H,1H3,(H,17,18)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = YEZNLOUZAIOMLT-UHFFFAOYSA-N
}}

'''Tolfenamic acid''' ('''Clotam''') is a member of the [[Nonsteroidal_anti-inflammatory_drug#Anthranilic_acid_derivatives_.28Fenamates.29|anthranilic acid derivatives]] (or fenamate) class of [[NSAID]] drugs discovered by scientists at Medica Pharmaceutical Company in Finland.<ref>Pentikäinen PJ, et al  [https://link.springer.com/article/10.1007/BF00544587 Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent]. Eur J Clin Pharmacol. 1981;19(5):359-65. {{PMID|7238564}}</ref>  Like other members of the class, it is a [[COX]] inhibitor and prevents formation of [[prostaglandins]].<ref name=LiverTox/>

It is used in the UK as a treatment for [[migraine]].<ref>NHS [http://www.nhs.uk/medicine-guides/pages/MedicineOverview.aspx?condition=Migraine%20Headache&medicine=Tolfenamic%20Acid&preparation= Tolfenamic Acid (Tolfenamic acid 200mg tablets)] Page accessed July 3, 2015</ref> It is generally not available in the US.<ref name=LiverTox>NIH LiverTox Database [http://livertox.nih.gov/MefenamicAcid.htm Mefenamic Acid] Last updated June 23, 2015. Page accessed July 3, 2015. Quote: "(fenamates generally not available in the United States, such as tolfenamic acid and flufenamic acid)"</ref> It is available in some Asian, Latin American and European countries as a generic drug for humans and for animals.<ref>Drugs.com [http://www.drugs.com/international/tolfenamic-acid.html Drugs.com international listings for tolfenamic acid] Page accessed July 3, 2015</ref> 

== References ==
<references/>

== External links ==
*[http://www.diseasesdatabase.com/ddb31603.htm Tolfenamic acid information] (Diseases Database)

{{Anti-inflammatory and antirheumatic products}}
{{GABAAR PAMs}}
{{Prostanoidergics}}
{{Serotonergics}}
{{Ion channel modulators}}

[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Antipyretics]]
[[Category:Analgesics]]
[[Category:Chloroarenes]]
[[Category:Anthranilic acids]]
[[Category:GABAA receptor positive allosteric modulators]]

{{musculoskeletal-drug-stub}}